Rate My Professor Peggy Chen

Chen's academic interests center on preclinical cardiac imaging for heart failure and atrial fibrillation, cardiovascular imaging, preclinical disease modelling, nanomedicine, and cardiovascular biology. She applies PET/CT, MRI, and molecular imaging approaches to study cardiac metabolism, fibrosis, and functional remodeling. As Chief Investigator B, she has attracted over $1.5 million in funding from sources such as the International Synchrotron Access Program Grants, Heart Foundation Vanguard Grant, and NHMRC Idea Grants. Through collaborations with leading experts in Australia and Japan, Chen advances the translation of imaging technologies for cardiovascular therapeutics. Her key publications encompass "Cardiovascular magnetic resonance imaging for sequential assessment of cardiac fibrosis in mice: technical advancements and reverse translation" (2024, American Journal of Physiology - Heart and Circulatory Physiology), "Prevention of Pathological Atrial Remodeling and Atrial Fibrillation: JACC State-of-the-Art Review" (2021, Journal of the American College of Cardiology), "Collagen-targeted tracers for molecular imaging of atrial fibrosis and sensitive detection of atrial fibrillation" (2025, npj Cardiovascular Health), and "β-blockade prevents coronary macro- and microvascular dysfunction induced by a high salt diet and insulin resistance in the Goto–Kakizaki rat" (2021, Clinical Science). These contributions highlight her influence in the field of cardiovascular research.